Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway

European Journal of Pharmacology

Volumn 672, Issue 1-3, 2011, Pages 159-168

  Hirasawa, Yasushi ^a,b   Sakai, Takayuki ^a   Ito, Masanori ^a   Yoshimura, Hiromitsu ^a   Feng, Yibin ^c   Nagamatsu, Tadashi ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Nihon Bioresearch Inc   (Japan)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Advanced glycation end product; Cholesterol; Diabetic nephropathy; ERK MAPK; Mesangial cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT CHOLESTEROL AGGREGATED BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; BOVINE SERUM ALBUMIN; CHOLESTEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 4; MITOGEN ACTIVATED PROTEIN KINASE 1; PYRIDOXAMINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GLOMERULUS; IN VITRO STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANIMALS; BUTADIENES; CATTLE; CELL PROLIFERATION; CHOLESTEROL; DIABETES MELLITUS; EXTRACELLULAR SPACE; GLYCOSYLATION END PRODUCTS, ADVANCED; LIPID PEROXIDATION; MALE; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 81255160771     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.185     Document Type: Article

References (39)

1. D.H. Atchley, M.F. Lopes-Virella, D. Zheng, D. Kenny, and G. Virella Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy Diabetologia 45 2002 1562 1571 (Pubitemid 35352050)
2. S.R. Axe, S.M. Katz, and R. Lavine Immunoglobulin deposition in the microvasculature of the streptozotocin-induced diabetic rat Lab. Invest. 45 1981 229 233 (Pubitemid 11000167)
3. A.D. Bhatwadekar, and V.S. Ghole Rapid method for the preparation of an AGE-BSA standard calibrator using thermal glycation J. Clin. Lab. Anal. 19 2005 11 15 (Pubitemid 40170595)
4. R. Bucala, Z. Makita, T. Koschinsky, A. Cerami, and H. Vlassara Lipid advanced glycosylation: pathway for lipid oxidation in vivo Proc. Natl. Acad. Sci. U. S. A. 90 1993 6434 6438 (Pubitemid 23207227)
5. R. Bucala, Z. Makita, G. Vega, S. Grundy, T. Koschinsky, A. Cerami, and H. Vlassara Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc. Natl. Acad. Sci. U. S. A. 91 1994 9441 9445 (Pubitemid 24297930)
6. S.M. Culbertson, E.I. Vassilenko, L.D. Morrison, and K.U. Ingold Paradoxical impact of antioxidants on post-Amadori glycoxidation: counterintuitive increase in the yields of pentosidine and Nepsilon- carboxymethyllysine using a novel multifunctional pyridoxamine derivative J. Biol. Chem. 278 2003 38384 38394 (Pubitemid 37221731)
7. T.P. Degenhardt, N.L. Alderson, D.D. Arrington, R.J. Beattie, J.M. Basgen, M.W. Steffes, S.R. Thorpe, and J.W. Baynes Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int. 61 2002 939 950 (Pubitemid 34175462)
8. Q. Fan, J. Liao, M. Kobayashi, M. Yamashita, L. Gu, T. Gohda, Y. Suzuki, L.N. Wang, S. Horikoshi, and Y. Tomino Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice Nephrol. Dial. Transplant. 19 2004 3012 3020 (Pubitemid 40057622)
9. T. Finkel, and N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 6809 2000 239 247 Nov 9
10. T. Hattori, S. Shindo, T. Hisada, N. Fujitsuka, T. Hibino, Y. Terazono, and M. Maruno Effects of Onpi-to (TJ-8117) on mesangial injury induced by anti Thy-1 antibody Nippon Yakurigaku Zasshi 105 1995 63 75
11. T. Hayashida, M. Decaestecker, and H.W. Schnaper Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells FASEB J. 17 2003 1576 1578
12. O. Higuchi, K. Nakagawa, T. Tsuzuki, T. Suzuki, S. Oikawa, and T. Miyazawa Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5′-phosphate as the inhibitor J. Lipid Res. 47 2006 964 974 (Pubitemid 43764692)
13. Y. Hirasawa, A. Muramatsu, Y. Suzuki, and T. Nagamatsu Insufficient expression of cyclooxygenase-2 protein is associated with retarded degradation of aggregated protein in diabetic glomeruli J. Pharmacol. Sci. 102 2006 173 181 (Pubitemid 44690974)
14. Y. Hirasawa, Y. Matsui, S. Ohtsu, K. Yamane, T. Toyoshi, K. Kyuki, T. Sakai, Y. Feng, and T. Nagamatsu Involvement of hyperglycemia in deposition of aggregated protein in glomeruli of diabetic mice Eur. J. Pharmacol. 601 2008 129 135
15. K. Iida, J.P. Del Rincon, D.S. Kim, E. Itoh, R. Nass, K.T. Coschigano, J.J. Kopchick, and M.O. Thorner Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist Endocrinology 145 2004 1564 1570 (Pubitemid 38402361)
16. M. Iwano, A. Kubo, T. Nishino, H. Sato, H. Nishioka, Y. Akai, H. Kurioka, Y. Fujii, M. Kanauchi, H. Shiiki, and K. Dohi Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus Kidney Int. 49 1996 1120 1126 (Pubitemid 26122715)
17. Y. Izuhara, M. Nangaku, R. Inagi, N. Tominaga, T. Aizawa, K. Kurokawa, C. van Ypersele de Strihou, and T. Miyata Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering J. Am. Soc. Nephrol. 16 2005 3631 3641 (Pubitemid 46211284)
18. W. Jiang, Y. Zhang, H. Wu, X. Zhang, H. Gan, J. Sun, Q. Chen, M. Guo, and Z. Zhang Role of cross-talk between the Smad2 and MAPK pathways in TGF-beta1-induced collagen IV expression in mesangial cells Int. J. Mol. Med. 26 2010 571 576
19. R. Kang, D. Tang, K.M. Livesey, N.E. Schapiro, M.T. Lotze, and H.J. Zeh The receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury Antioxid. Redox Signal. 15 8 2011 2175 2184 (Oct 15)
20. H.S. Lee Oxidized LDL, glomerular mesangial cells and collagen Diabetes Res. Clin. Pract. 45 1999 117 122 (Pubitemid 29457758)
21. H.S. Lee, and Y.S. Kim Identification of oxidized low density lipoprotein in human renal biopsies Kidney Int. 54 1998 848 856
22. B.W. Lee, H.Y. Chae, S.J. Kwon, S.Y. Park, J. Ihm, and S.H. Ihm RAGE ligands induce apoptotic cell death of pancreatic beta-cells via oxidative stress Int. J. Mol. Med. 26 2010 813 818
23. M.F. Lopes-Virella, G. Virella, T.J. Orchard, S. Koskinen, R.W. Evans, D.J. Becker, and K.Y. Forrest Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus Clin. Immunol. 90 1999 165 172 (Pubitemid 29162161)
24. C. Lu, J.C. He, W. Cai, H. Liu, L. Zhu, and H. Vlassara Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 11767 11772 (Pubitemid 39099304)
25. H. Makino, K. Shikata, K. Hironaka, M. Kushiro, Y. Yamasaki, H. Sugimoto, Z. Ota, N. Araki, and S. Horiuchi Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy Kidney Int. 48 1995 517 526
26. T. Miyata, C. van Ypersele de Strihou, Y. Ueda, K. Ichimori, R. Inagi, H. Onogi, N. Ishikawa, M. Nangaku, and K. Kurokawa Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms J. Am. Soc. Nephrol. 13 2002 2478 2487
27. H.O. Mowri, B. Frei, and J.F. Keaney Jr. Glucose enhancement of LDL oxidation is strictly metal ion dependent Free Radic. Biol. Med. 29 2000 814 824
28. T. Nagamatsu, Y. Hirasawa, Y. Matsui, S. Ohtsu, K. Yamane, T. Toyoshi, K. Kyuki, and Y. Suzuki Increase in the deposition of aggregated protein in the glomeruli of spontaneously diabetic mice J. Pharmacol. Sci. 99 2005 287 293 (Pubitemid 41686453)
29. K. Nakagawa, J.H. Oak, O. Higuchi, T. Tsuzuki, S. Oikawa, H. Otani, M. Mune, H. Cai, and T. Miyazawa Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes J. Lipid Res. 46 2005 2514 2524 (Pubitemid 41532540)
30. M. Nangaku, T. Miyata, T. Sada, M. Mizuno, R. Inagi, Y. Ueda, N. Ishikawa, H. Yuzawa, H. Koike, C. van Ypersele de Strihou, and K. Kurokawa Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model J. Am. Soc. Nephrol. 14 2003 1212 1222 (Pubitemid 36514663)
31. J. Oak, K. Nakagawa, and T. Miyazawa Synthetically prepared Amadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions FEBS Lett. 481 2000 26 30 (Pubitemid 30662371)
32. D.L. Price, P.M. Rhett, S.R. Thorpe, and J.W. Baynes Chelating activity of advanced glycation end-product inhibitors J. Biol. Chem. 276 2001 48967 48972
33. G. Pugliese, F. Pricci, G. Romeo, F. Pugliese, P. Mene, S. Giannini, B. Cresci, G. Galli, C.M. Rotella, H. Vlassara, and U. Di Mario Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism Diabetes 46 1997 1881 1887 (Pubitemid 27456425)
34. H. Roa, C. Gajardo, E. Troncoso, V. Fuentealba, C. Escudero, A. Yanez, L. Sobrevia, M. Pastor-Anglada, C. Quezada, and R. San Martin Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats FEBS Lett. 583 2009 3192 3198
35. S. Wang, and R. Hirschberg BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells Am. J. Physiol. Renal Physiol. 284 2003 F1006 F1013 (Pubitemid 36443585)
36. Y.W. Yoon, T.S. Kang, B.K. Lee, W. Chang, K.C. Hwang, J.H. Rhee, P.K. Min, B.K. Hong, S.J. Rim, and H.M. Kwon Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy Exp. Mol. Med. 40 2008 398 406
37. H. Yoshimura, T. Sakai, Y. Kuwahara, M. Ito, K. Tsuritani, Y. Hirasawa, and T. Nagamatsu Effects of kynurenine metabolites on mesangial cell proliferation and gene expression Exp. Mol. Pathol. 87 2009 70 75
38. J.B. Zhao, A. Mikata, and K. Azuma Immunoglobulin deposits in diabetic microangiopathy. Observations in autopsy materials Acta Pathol. Jpn. 40 1990 729 734
39. F. Zheng, A. Fornoni, S.J. Elliot, Y. Guan, M.D. Breyer, L.J. Striker, and G.E. Striker Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation Am. J. Physiol. Renal Physiol. 282 2002 F639 F648 (Pubitemid 34654511)